Document:

Form of Global Security relating thereto

 EXHIBIT 4.2 
 (Face of Security) 
 THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND
IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE THEREOF. THIS SECURITY MAY NOT BE EXCHANGED IN WHOLE OR IN PART FOR A SECURITY REGISTERED, AND NO TRANSFER OF THIS SECURITY IN WHOLE OR IN PART MAY BE REGISTERED, IN THE NAME OF ANY PERSON OTHER
THAN SUCH DEPOSITARY OR A NOMINEE THEREOF, EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE. 
 UNLESS THIS CERTIFICATE IS PRESENTED BY
AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO BARCLAYS BANK PLC, OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME
OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE
OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 
 BY PURCHASING THIS SECURITY, THE HOLDER AGREES TO CHARACTERIZE THIS SECURITY FOR ALL U.S. FEDERAL INCOME TAX PURPOSES AS PROVIDED IN SECTION 7 ON THE FACE OF THIS SECURITY. 
  

 (Face of Security continued on next page) 
 1 

			
	CUSIP No. 06738C778	  	ISIN: •
		  	Common Code: •

 BARCLAYS BANK PLC 
 MEDIUM-TERM NOTES, SERIES A 
  

 iPathSM Exchange Traded
Notes 
 due May 25, 2036 
 (Linked to the Dow Jones – AIG Commodity Index Total ReturnSM)

 The following terms apply to this Security. Capitalized terms that are not defined the first time they are used in this Security shall have the
meanings indicated elsewhere in this Security. 
  

 (Face of Security continued on next page) 
 2 

			
	Face Amount: $•.	  	Early Redemption: The Holder may, subject to the notification requirements provided under Section 5 hereof, require the Company to redeem the Holder’s Securities in
whole or in part on any Redemption Date during the term of the Securities. If the Holder requires the Company to redeem the Holder’s Securities on any Redemption Date, the Holder will receive a cash payment equal to the principal amount of the
Holder’s Securities times the Index Factor on the applicable Valuation Date minus the Investor Fee on the applicable Valuation Date. The Company shall not be required to redeem fewer than 50,000 Securities at one time, provided
that the Company may from time to time in its sole discretion reduce, in part or in whole, this minimum redemption amount on a consistent basis for all Holders who hold Securities at the time the reduction becomes effective.
	Index: The Dow Jones-AIG Commodity Index Total ReturnSM.	  
	Inception Date: May 23, 2006.	  
	Interest Rate: The principal of this Security shall not bear interest.	  
	Denomination: $50.	  
	Payment at Maturity: On the Maturity Date, the Company shall redeem this Security by paying to the Holder a cash payment equal to the principal amount of the Holder’s Securities
times the Index Factor on the Final Valuation Date minus the Investor Fee on the Final Valuation Date unless such Securities were previously redeemed on a Redemption Date as provided under “Early Redemption”.	  
		
		  	Calculation Agent: Barclays Bank PLC.
		
		  	Defeasance: Neither full defeasance nor covenant defeasance applies to this Security.
		
		  	Listing: New York Stock Exchange.

  

 (Face of Security continued on next page) 
 3 

 “Dow Jones,” “AIG®”, “Dow-Jones-AIG Commodity IndexSM” and “DJAIGCISM” are service marks of Dow
Jones & Company, Inc. and American International Group, Inc., as the case may be, and have been licensed for use for certain purposes by Barclays Bank PLC. The Index was designed by AIG International Inc. (“AIGI”) and is owned by
AIG Financial Products Corp. (“AIG-FP”). The Index is calculated by Dow Jones & Company, Inc. (“Dow Jones”) in conjunction with AIG-FP. Barclays Bank PLC’s Securities based on the Dow Jones-AIG Commodity Index Total
ReturnSM, are not sponsored, endorsed, sold or promoted by Dow Jones, AIG-FP, American International Group, or any
of their respective subsidiaries or affiliates, and none of Dow Jones, AIG-FP, American International Group, or any of their respective subsidiaries or affiliates, makes any representation regarding the advisability of investing in such Securities.

 The Securities are not sponsored, endorsed, sold or promoted by Dow Jones, American International Group, AIG-FP or any of their respective subsidiaries or
affiliates. None of Dow Jones, American International Group, AIG-FP or any of their affiliates makes any representation or warranty, express or implied, to the owners of the Securities or any member of the public regarding the advisability of
investing in securities or commodities generally or in the Securities particularly. The only relationship of such persons to Barclays Bank PLC is the licensing of certain trademarks, trade names and service marks and of the Dow Jones-AIG Commodity
Index Total ReturnSM, which is determined, composed and calculated by Dow Jones in conjunction with AIG-FP without
regard to Barclays Bank PLC or the Securities. Dow Jones and AIG-FP have no obligation to take the needs of Barclays Bank PLC or the owners of the Securities into consideration in determining, composing or calculating the Dow Jones-AIG Commodity
Index Total ReturnSM. None of Dow Jones, American International Group, AIG-FP or any of their respective
subsidiaries or affiliates is responsible for or has participated in the determination of the timing of, prices at or quantities of the Securities to be issued or in the determination or calculation of the equation by which the Securities are to be
converted into cash. None of Dow Jones, American International Group, AIG-FP or any of their respective subsidiaries or affiliates shall have any obligation or liability in connection with the administration marketing or trading of the Securities.
Notwithstanding the foregoing, AIG-FP, American International Group and their respective affiliates may independently issue and/or sponsor financial products unrelated to the Securities currently being issued by Barclays Bank PLC, but which may be
similar to and competitive with the Securities. In addition, American International Group, AIG-FP and their respective subsidiaries or affiliates actively trade commodities, commodity indexes and commodity futures (including the Dow Jones-AIG
Commodity IndexSM and the Dow Jones-AIG Commodity Index Total ReturnSM) as well as swaps, options and derivatives which are linked to commodity indexes and commodity futures. It is possible that this trading activity will affect
the value of the Dow Jones-AIG Commodity Index Total ReturnSM and the Securities. This Security does not relate to
the exchange-traded physical commodities underlying any of the Dow Jones-AIG Commodity Index Total ReturnSM
components. Purchasers of the Securities should not conclude that the inclusion of a futures contract in the Dow Jones-AIG Commodity Index Total ReturnSM is any form of investment recommendation of the futures contract of the underlying exchange-traded physical commodity by Dow Jones, American International Group, AIG-FP or any of their respective
subsidiaries or affiliates. None of Dow Jones, American International Group, AIG-FP or any of their respective subsidiaries or affiliates has made any due diligence inquiries with respect to the exchange-traded futures contracts which comprise the
Dow Jones-AIG Commodity Index Total ReturnSM in connection with the Securities. 
 NONE OF DOW JONES, AMERICAN INTERNATIONAL GROUP, AIG-FP OR ANY OF THEIR AFFILIATES GUARANTEES THE ACCURACY AND/OR THE COMPLETENESS OF THE DOW JONES-AIG
COMMODITY INDEX TOTAL RETURNSM OR ANY DATA INCLUDED THEREIN AND NONE OF DOW JONES, AMERICAN INTERNATIONAL GROUP,
AIG-FP OR ANY OF THEIR RESPECTIVE SUBSIDIARIES OR AFFILIATES SHALL HAVE ANY LIABILITY FOR ANY ERRORS, OMISSIONS OR INTERRUPTIONS THEREIN. NONE OF DOW JONES, AMERICAN INTERNATIONAL GROUP, AIG-FP OR ANY OF THEIR RESPECTIVE SUBSIDIARIES OR AFFILIATES
MAKES ANY WARRANTY, EXPRESS OR IMPLIED, AS TO THE RESULTS TO BE OBTAINED BY 

  

 (Face of Security continued on next page) 
 4 

 
BARCLAYS BANK PLC, OWNERS OF THE SECURITIES, OR ANY OTHER PERSON OR ENTITY FROM THE USE OF THE DOW JONES-AIG COMMODITY INDEX TOTAL RETURNSM OR ANY DATA INCLUDED THEREIN. NONE OF DOW JONES, AMERICAN INTERNATIONAL GROUP, AIG-FP OR ANY OF THEIR RESPECTIVE SUBSIDIARIES
OR AFFILIATES MAKES ANY EXPRESS OR IMPLIED WARRANTIES, AND EXPRESSLY DISCLAIMS ALL WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE WITH RESPECT TO DOW JONES-AIG COMMODITY INDEX TOTAL RETURNSM OR ANY DATA INCLUDED THEREIN. WITHOUT LIMITING ANY OF THE FOREGOING, IN NO EVENT SHALL DOW JONES, AMERICAN INTERNATIONAL GROUP, AIG-FP OR ANY OF
THEIR RESPECTIVE SUBSIDIARIES OR AFFILIATES HAVE ANY LIABILITY FOR ANY LOST PROFITS OR INDIRECT, PUNITIVE, SPECIAL OR CONSEQUENTIAL DAMAGES OR LOSSES, EVEN IF NOTIFIED OF THE POSSIBILITY THEREOF. THERE ARE NO THIRD PARTY BENEFICIARIES OF ANY
AGREEMENTS OR ARRANGEMENTS AMONG DOW JONES, AIG-FP AND BARCLAYS BANK PLC, OTHER THAN AMERICAN INTERNATIONAL GROUP. 
 OTHER TERMS: 
 All terms used in this Security that are not defined in this Security but are defined in the Indenture referred to on the reverse of this Security shall
have the meanings assigned to them in the Indenture. Section headings on the face of this Security are for convenience only and shall not affect the construction of this Security. 
 “Business Day” means any day that is not a Saturday, a Sunday or a day on which banking institutions in London or New York City generally
are authorized or obligated by law, regulation or executive order to close. 
 “Default Amount” means, on any day, an amount
in U.S. dollars, as determined by the Calculation Agent in its sole discretion, equal to the cost of having a Qualified Financial Institution (selected as provided below) expressly assume the due and punctual payment of the principal of this
Security, and the performance or observance of every covenant hereof and of the Indenture on the part of the Company to be performed or observed with respect to this Security (or to undertake other obligations providing substantially equivalent
economic value to the Holder of this Security as the Company’s obligations hereunder). Such cost will equal (i) the lowest amount that a Qualified Financial Institution would charge to effect such assumption (or undertaking) plus
(ii) the reasonable expenses (including reasonable attorneys’ fees) incurred by the Holder of this Security in preparing any documentation necessary for such assumption (or undertaking). During the Default Quotation Period, each Holder of
this Security and the Company may request a Qualified Financial Institution to provide a quotation of the amount it would charge to effect such assumption (or undertaking). If either party obtains a quotation, it must notify the other party in
writing of the quotation. The amount referred to in clause (i) of this paragraph will equal the lowest (or, if there is only one, the only) quotation so obtained, and as to which notice is so given, during the Default Quotation Period;
provided that, with respect to any quotation, the party not obtaining the quotation may object, on reasonable and significant grounds, to the effectuation of such assumption (or undertaking) by the Qualified Financial Institution providing
such quotation and notify the other party in writing of such grounds within two Business Days after the last day of the Default Quotation Period, in which case that quotation will be disregarded in determining the Default Amount. The
“Default Quotation Period” shall be the period beginning on the day the Default Amount first becomes due and ending on the third Business Day after such due date, unless no such quotation is obtained, or unless every such quotation
so obtained is objected to within five Business Days after such due date as provided above, in which case the Default Quotation Period will continue until the third Business Day after the 

  

 (Face of Security continued on next page) 
 5 

 
first Business Day on which prompt notice of a quotation is given as provided above, unless such quotation is objected to as provided above within five
Business Days after such first Business Day, in which case, the Default Quotation Period will continue as provided in this sentence. Notwithstanding the foregoing, if the Default Quotation Period (and the subsequent two Business Day objection
period) has not ended prior to the Final Valuation Date, then the Default Amount will equal the Face Amount. 
 “Final Valuation
Date” means May 22, 2036, or if such date is not a Trading Day, the next succeeding Trading Day; provided, however, that if the Calculation Agent determines that a Market Disruption Event occurs or is continuing on such
date, the Final Valuation Date will be the first following Trading Day on which the Calculation Agent determines that a Market Disruption Event does not occur and is not continuing, provided that in no event will the Final Valuation Date be
postponed by more than five Trading Days. 
 “Index Component” means, with respect to the Securities, any of the futures
contracts on physical commodities that comprise the Index. 
 “Index Factor” means, on any given day, the amount equal to the
closing value of the Index on that day divided by the closing value of the Index on the Inception Date. 
 “Investor
Fee” means the amount equal to 0.75% per year times the principal amount of the Holder’s Securities times the Index Factor, calculated on a daily basis in the following manner: (i) the Investor Fee on the
Inception Date shall equal zero; and (ii) on each subsequent calendar day until and including the Final Valuation Date or, in the case of Securities with respect to which the Holder has exercised its right of Early Redemption, the applicable
Valuation Date, the Investor Fee will increase by an amount equal to 0.75% times the principal amount of the Holder’s Securities times the Index Factor on that day (or, if such day is not a Trading Day, the Index Factor on the
immediately preceding Trading Day) divided by 365. 
 “Market Disruption Event” means, with respect to the Securities,
in the opinion of the Calculation Agent and determined in its sole discretion: (i) a material limitation, suspension or disruption in the trading of any Index Component which results in a failure by the trading facility on which the relevant
contract is traded to report a daily contract reference price; (ii) the daily contract reference price for any Index Component has increased or decreased from the previous day’s daily contract reference price by the maximum amount
permitted under the applicable rules or procedures of the relevant trading facility; (iii) AIG-FP and Dow Jones fail to publish the closing value of the Index or the applicable trading facility or other price source fails to announce or publish
the daily contract reference price for one or more Index Components; (iv) any other event, if the Calculation Agent determines in its sole discretion that the event materially interferes with the ability of Barclays Bank PLC or the ability of
any affiliates of Barclays Bank PLC to unwind all or a material portion of a hedge with respect to the Securities that Barclays Bank PLC or any of its affiliates have effected or may effect. The following events will not be Market Disruption Events:
(a) a limitation on the hours or numbers of days of trading on a trading facility on which any Index Component is traded, but only if the limitation results from an announced change in the regular business hours of the relevant market; or
(b) a decision by a trading facility to permanently discontinue trading in any Index Component. 
 “Maturity Date” means
May 25, 2036, provided that if such date is not a Business Day, the Maturity Date will be the next succeeding Business Day; provided, however, that if the fifth Business Day preceding May 25, 2036 does not qualify as the
Final Valuation Date referred to above, then the Maturity Date will be the fifth Business Day following the Final Valuation Date. 
  

 (Face of Security continued on next page) 
 6 

 “Qualified Financial Institution” means, at any time, a financial institution organized
under the laws of any jurisdiction in the United States of America or Europe that at such time has outstanding debt obligations with a stated maturity of one year or less from the date of issue and rated A-1 or higher by Standard &
Poor’s, a division of The McGraw Hill Companies, Inc., Ratings Group (or any successor) or P-1 or higher by Moody’s Investors Service, Inc. (or any successor) or, in either case, such other comparable rating, if any, then used by such
rating agency. 
 “Redemption Date” means the third Business Day following each Valuation Date other than the Final Valuation
Date. 
 “Successor Index” means any substitute index approved by the Calculation Agent as a Successor Index pursuant to
Section 3 hereof. 
 “Trading Day” means any day on which (i) the value of the Index is published by AIG-FP and Dow
Jones; (ii) trading is generally conducted on the New York Stock Exchange; and (iii) trading is generally conducted on the markets on which the Index Components are traded, in each case as determined by the Calculation Agent in its sole
discretion. 
 “Valuation Date” means each Thursday from May 25, 2006 to May 22, 2036, inclusive, or if such date
is not a Trading Day, the next succeeding Trading Day; provided, however, that if the Calculation Agent determines that a Market Disruption Event occurs or is continuing on such date, the Valuation Date will be the first following
Trading Day on which the Calculation Agent determines that a Market Disruption Event does not occur and is not continuing, provided that in no event will any Valuation Date be postponed by more than five Trading Days. 
  

 Promise to Pay at Maturity or
Upon Early Redemption 
 Barclays Bank PLC, a public limited company duly organized and existing under the laws of England and Wales
(herein called the “Company,” which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay (or cause to be paid) to Cede & Co., as nominee for The
Depository Trust Company, or registered assigns, the amount as calculated and provided under (i) “Early Redemption” and elsewhere on the face this Security on the applicable Redemption Date, in the case of any Securities in respect of
the which the Holder exercises such Holder’s right to require the Company to redeem such Holder’s Securities prior to the Maturity Date, or (ii) “Payment at Maturity” and elsewhere on the face of this Security on the
Maturity Date, in the case of all other Securities. 
 Payment of Interest 
 The principal of this Security shall not bear interest. 
 Discontinuance or Modification of the Index; Market Disruption Event 
 If Dow Jones and AIG-FP
discontinue publication of the Index and Dow Jones and AIG-FP or any other Person or entity publishes an index that the Calculation Agent determines is comparable to the Index and approves as a Successor Index, then the Calculation Agent will
determine the value of the Index on the applicable Valuation Date and the amount payable on the Maturity Date or any Redemption Date by reference to such Successor Index. 
  

 (Face of Security continued on next page) 
 7 

 If the Calculation Agent determines that the publication of the Index is discontinued and that there is
no Successor Index, or that the closing value of the Index is not available because of a Market Disruption Event or for any other reason, on any Valuation Date, or if for any other reason the Index is not available to the Company or the Calculation
Agent on any Valuation Date, the Calculation Agent will determine the amount payable by a computation methodology that the Calculation Agent determines will as closely as reasonably possible replicate the Index. 
 If the Calculation Agent determines that the Index, the Index Components or the method of calculating the Index has been changed at any time in any
respect, including, without limitation, any addition, deletion or substitution and any reweighting or rebalancing of Index Components, and whether the change is made by AIG-FP and Dow Jones under their existing policies or following a modification
of those policies, is due to the publication of a Successor Index, is due to events affecting one or more of the Index Components, or is due to any other reason, then the Calculation Agent will be permitted (but shall not be required) to make such
adjustments to the Index or method of calculating the Index as it believes are appropriate to ensure that the value of the Index used to determine the amount payable on the Maturity Date or upon Early Redemption is equitable. 
 The Calculation Agent shall have the right to postpone a Valuation Date, and thus the determination of the value of the Index, if the Calculation Agent
determines that, on such Valuation Date, a Market Disruption Event occurs or is continuing in respect of any Index Component. If such a postponement occurs, the Calculation Agent shall determine the value of the Index Components unaffected by the
Market Disruption Event by using the closing value of such Index Component or Index Components on the scheduled Valuation Date and shall determine the value of any affected Index Component by using the closing value of such Index Component on the
first Trading Day after that day on which no Market Disruption Event occurs or is continuing with respect to such Index Component. In no event, however, may the Calculation Agent postpone a Valuation Date by more than five Trading Days. 

In the event that a Valuation Date is postponed until the fifth Trading Day following the scheduled Valuation Date, but a Market Disruption Event
occurs and is continuing on such day, that day shall nevertheless be a Valuation Date, and the Calculation Agent shall determine the value of the Index on such day by a good faith estimate of the value of the Index that would have prevailed in the
absence of a Market Disruption Event. 
 The Calculation Agent shall have the right to make all determinations and adjustments with respect to
the Index in its sole discretion. 
 Payment at Maturity or Upon Early Redemption 
 The payment of this Security that becomes due and payable on the Maturity Date or on a Redemption Date, as the case may be, shall be the cash amount that
must be paid to redeem this Security as provided above under “Payment at Maturity” and “Early Redemption”, respectively. The payment of this Security that becomes due and payable upon acceleration of the Maturity Date hereof
after an Event of Default has occurred pursuant to the Indenture shall be the Default Amount. When the principal referred to in either of the two preceding sentences has been paid as provided herein (or such payment has been made available), the
principal of this Security shall be deemed to have been paid in full, whether or not this Security shall have been surrendered for payment or cancellation. References to the payment at maturity or upon early redemption of this Security on any day
shall be deemed to mean the payment of cash that is payable on such day as provided in this Security. Notwithstanding the foregoing, solely for the purpose of determining whether any consent, waiver, notice or other action to be given or taken by
Holders of Securities pursuant to the Indenture has been given or taken by Holders of Outstanding Securities in the requisite aggregate principal amount, the 

  

 (Face of Security continued on next page) 
 8 

 
principal amount of this Security will be deemed to equal the Face Amount. This Security shall cease to be Outstanding as provided in the definition of such
term in the Indenture when the principal of this Security shall be deemed to have been paid in full as provided above. 
 Redemption
Mechanics 
 Subject to the minimum redemption amount provided under “Early Redemption”, the Holder may require the Company
to redeem the Holder’s Securities on any Redemption Date during the term of the Securities provided that such Holder (i) delivers a notice of redemption to the Company via electronic mail by no later than 11:00 a.m. New York time on
the Business Day prior to the applicable Valuation Date; (ii) delivers a signed confirmation of redemption to the Company via facsimile by no later than 4:00 p.m. New York time on the same day; (iii) instructs the Holder’s DTC
custodian to book a delivery versus payment trade with respect to the Holder’s Securities on the applicable Valuation Date at a price equal to the principal amount of the Holder’s Securities times the Index Factor on the applicable
Valuation Date minus the Investor Fee on the applicable Valuation Date, facing Barclays Capital DTC 5101; and (iv) causes the Holder’s DTC custodian to deliver the trade as booked for settlement via DTC prior to 10:00 a.m. New York
time on the applicable Redemption Date, which shall be the third Business Day following the applicable Valuation Date. 
 Role of
Calculation Agent 
 The Calculation Agent will be solely responsible for all determinations and calculations regarding the value of
the Securities, including at maturity or upon early redemption; Market Disruption Events; Business Days; Trading Days; the Investor Fee; the Default Amount; the closing value of the Index on the Inception Date and on any Valuation Date; the Maturity
Date; Redemption Dates; the amount payable on the Securities and all such other matters as may be specified elsewhere herein as matters to be determined by the Calculation Agent. The Calculation Agent shall make all such determinations and
calculations in its sole discretion, and absent manifest error, all determinations of the Calculation Agent shall be final and binding on the Company, the Holder and all other Persons having an interest in this Security, without liability on the
part of the Calculation Agent. 
 The Company shall take such action as shall be necessary to ensure that there is, at all relevant times, a
financial institution serving as the Calculation Agent hereunder. The Company may, in its sole discretion at any time and from time to time, upon written notice to the Trustee, but without notice to the Holder of this Security, terminate the
appointment of any Person serving as the Calculation Agent and appoint another Person (including any Affiliate of the Company) to serve as the Calculation Agent. Insofar as this Security provides for the Calculation Agent to determine the value of
the Index on any date or other information from any institution or other source, the Calculation Agent may do so from any source or sources of the kind contemplated or otherwise permitted hereby notwithstanding that any one or more of such sources
are the Calculation Agent, Affiliates of the Calculation Agent or Affiliates of the Company. 
 Tax Characterization

 By its purchase of this Security, the Holder, on behalf of itself and any other Person having a beneficial interest in this Security,
hereby agrees with the Company (in the absence of an administrative determination or judicial ruling to the contrary) to characterize this Security for all U.S. federal income tax purposes as a pre-paid contract with respect to the Index.

  

 (Face of Security continued on next page) 
 9 

 Payment 
 Payment of any amount payable on this Security will be made in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts. Payment will be
made to an account designated by the Holder (in writing to the Company and the Trustee on or before the applicable Valuation Date) and acceptable to the Company or, if no such account is designated and acceptable as aforesaid, at the office or
agency of the Company maintained for that purpose in The City of New York, provided, however, that payment on the Maturity Date or any Redemption Date shall be made only upon surrender of this Security at such office or agency
(unless the Company waives surrender). Notwithstanding the foregoing, if this Security is a Global Security, any payment may be made pursuant to the Applicable Procedures of the Depositary as permitted in said Indenture. 
 Reverse of this Security 
 Reference is hereby made to the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same effect as if set forth at this place. 
 Certificate of Authentication 
 Unless the certificate of authentication hereon has been executed by the Trustee referred to on the reverse hereof by manual signature, this Security shall not be entitled to any benefit under the Indenture or be valid or obligatory for any
purpose. 
  

 (Face of Security continued on next page) 
 10 

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed. 
  

			
	BARCLAYS BANK PLC
		
	By:	 	  
		 	Name:
		 	Title:

  

			
		
	By:	 	  
		 	Name:
		 	Title:

 This is one of the Securities of the series designated herein and referred to in the
Indenture. 
 Dated: 
  

			
	THE BANK OF NEW YORK
		
	By:	 	  
		 	Name:
		 	Title:

  

 (Reverse of Security continued on next page) 
 11 

 (Reverse of Security) 
 This Security is one of a duly authorized issue of securities of the Company (herein called the “Securities”) issued and to be issued in one or more series under an Indenture, dated as of
September 16, 2004 (herein called the “Indenture,” which term shall have the meaning assigned to it in such instrument), between the Company and The Bank of New York, as Trustee (herein called the “Trustee,”
which term includes any successor trustee under the Indenture), and reference is hereby made to the Indenture for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee, the Holders
of the Securities and of the terms upon which the Securities are, and are to be, authenticated and delivered. Insofar as the provisions of the Indenture may conflict with the provisions set forth on the face of this Security, the latter shall
control for purposes of this Security. 
 This Security is one of the series designated on the face hereof, limited to an aggregate initial
offering price not to exceed $10,000,000,000 (or the equivalent thereof in any other currency or currencies or currency units), which amount may be increased at the option of the Company if in the future it determines that it may wish to sell
additional Securities of this series. References herein to “this series” mean the series designated on the face hereof. 
 Payments under the Securities will be made without deduction or withholding for, or on account of, any and all present or future income, stamp and other taxes, levies, imposts, duties, charges, fees, deductions or withholdings
(“Taxes”) now or hereafter imposed, levied, collected, withheld or assessed by or on behalf of the United Kingdom or any political subdivision or authority thereof or therein having the power to tax (each a “Taxing
Jurisdiction”), unless such deduction or withholding is required by law. If any such Taxes are at any time required by a Taxing Jurisdiction to be deducted or withheld, the Company will, subject to the exceptions and limitations set forth
in Section 10.04 of the Indenture, pay such additional amounts of the principal of such Security and any other amounts payable on such Security (“Additional Amounts”) as may be necessary in order that the net amounts paid to
the Holder of any Security, after such deduction or withholding, shall equal the amounts of the principal of such Security and any other amounts payable on such Security which would have been payable in respect of such Security had no such deduction
or withholding been required. 
 If at any time the Company determines that as a result of a change in or amendment to the laws or
regulations of a Taxing Jurisdiction (including any treaty to which such Taxing Jurisdiction is a party), or a change in an official application or interpretation of such laws or regulations (including a decision of any court or tribunal), either
generally or in relation to any particular Securities, which change, amendment, application or interpretation becomes effective on or after the Original Issue Date in making any payment of, or in respect of, the principal amount of the Securities,
the Company would be required to pay any Additional Amounts with respect thereto, then the Securities will be redeemable upon not less than 35 nor more than 60 days’ notice by mail, at any time thereafter, in whole but not in part, at the
election of the Company as provided in the Indenture at a redemption price equal to the principal amount thereof. 
 The Indenture permits,
with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the
Company and the Trustee with the consent of the Holders of a majority in principal amount of the Securities at the time Outstanding of all series to be affected 

  

 (Reverse of Security continued on next page) 
 12 

 
(considered together as one class for this purpose). The Indenture also contains provisions (i) permitting the Holders of a majority in aggregate
principal amount of the Securities at the time Outstanding of all series to be affected under the Indenture (considered together as one class for this purpose), on behalf of the Holders of all Securities of such series, to waive compliance by the
Company with certain provisions of the Indenture and (ii) permitting the Holders of a majority in aggregate principal amount of the Securities at the time Outstanding of any series to be affected under the Indenture (with each such series
considered separately for this purpose), on behalf of the Holders of all Securities of such series, to waive certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Security shall be
conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is
made upon this Security. 
 As provided in and subject to the provisions of the Indenture, the Holder of this Security shall not have any
right to institute any proceeding, judicial or otherwise, with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Trustee written notice of
a continuing Event of Default with respect to the Securities of this series, the Holders of not less than 25% in aggregate principal amount of the Securities of this series at the time Outstanding shall have made written request to the Trustee to
institute proceedings in respect of such Event of Default as Trustee and offered the Trustee reasonable indemnity against the costs, expenses and liabilities to be incurred in compliance with such request, and the Trustee shall not have received
from the Holders of a majority in principal amount of Securities of this series at the time Outstanding a direction inconsistent with such request, and shall have failed to institute any such proceeding, for 60 days after receipt of such notice,
request and offer of indemnity. The foregoing shall not apply to any suit instituted by the Holder of this Security for the enforcement of any payment of principal hereof on or after the respective due dates expressed herein. 
  

 (Reverse of Security continued on next page) 
 13 

 No reference herein to the Indenture and no provision of this Security or of the Indenture shall alter or
impair the obligation of the Company, which is absolute and unconditional, to pay the principal of this Security as herein provided. 
 As
provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Security is registrable in the Senior Debt Security Register, upon surrender of this Security for registration of transfer at the office or agency
of the Company in any place where the principal of this Security is payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company and the Senior Debt Security Registrar duly executed by, the Holder
hereof or his attorney duly authorized in writing. Thereupon one or more new Securities of this series and of like tenor, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or
transferees. 
 This Security, and any other Securities of this series and of like tenor, are issuable only in registered form without
coupons in denominations of any multiple of $50. As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal amount of Securities of this series and of
like tenor of a different authorized denomination, as requested by the Holder surrendering the same. 
 No service charge shall be made for
any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 
 Prior to due presentment of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat
the Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary. 
 This Security and the Indenture shall be governed by and construed in accordance with the laws of the State of New York. 
  

 14Tri-Party Agreement

 EXHIBIT 10.1 
 TRI-PARTY AGREEMENT 
 THIS TRI-PARTY AGREEMENT (this “Agreement”) is made and
entered into as of February 3, 2005 by and among EMERGYSTAT, INC., a Mississippi corporation, EMERGYSTAT OF SULLIGENT, INC., an Alabama corporation, EXTENDED EMERGENCY MEDICAL SERVICES, INC., an Alabama corporation, MED EXPRESS OF MISSISSIPPI, LLC,
a Mississippi limited liability company (collectively, “Borrower”), BAD TOYS HOLDINGS, INC., a Nevada corporation (“Purchaser”), and GENERAL ELECTRIC CAPITAL CORPORATION, a Delaware corporation
(“Lender”). 
 RECITALS 
  

			
	 FIRST:
	  	Borrower and Lender are parties to that certain Loan And Security Agreement dated as of April 30, 2003 (as amended, modified, and/or restated from time to time, the “Loan
Agreement”), as modified by the Forbearance Agreements.
		
	 SECOND:
	  	Borrower has been in default under the Loan Agreement for an extensive period of time pursuant to Existing Defaults and other matters stated in the Forbearance Agreements. During that time,
Borrower has made multiple requests asking Lender to continue to forbear from exercising its collection and other rights, and to make further advances under the Loan Agreement. Lender has agreed to those requests by Borrower under the terms and
conditions of the Forbearance Agreements.
		
	 THIRD:
	  	The last day of the current forbearance period is January 31, 2005. Borrower has represented to Lender that (a) the shareholders of Emergystat, Inc. have entered into an agreement dated
                    , 2            , to transfer ninety percent (90%) of
the issued and outstanding capital stock of Emergystat, Inc. to Southland Health Services, Inc. (“Southland Health Services”), (b) the shareholders of Emergystat of Sulligent, Inc. have entered into an agreement dated
                    , 2            , to transfer ninety percent (90%) of
the issued and outstanding capital stock of Emergystat of Sulligent, Inc. to Southland Health Services (the agreements described in subsections (a) and (b) shall be referred to collectively in this Agreement as the, “Emergystat Purchase
Agreement”, and the stock purchases described in subsections (a) and (b) shall be referred to collectively in this Agreement as the (“Emergystat Stock Purchase”), and (c) Southland Health Services
has entered into a Capital Stock Purchase Agreement, dated on or about December 27, 2004 (the “Southland Purchase Agreement”) with the Purchaser, whereby the Purchaser is to acquire all of the equity interests of Southland
Health Services, and thereby indirectly acquire the entities comprising Borrower (the “Southland Stock Purchase”). Borrower and Purchaser also have represented to Lender that the Emergystat Stock Purchase, together with the
Southland Stock Purchase, will result in Borrower’s indefeasible payment in full of all Obligations owing to Lender.
		
	 FOURTH:
	  	Without Lender’s prior written consent, a change in the legal ownership of the capital stock of Borrower would be a breach of the negative covenant set forth in Section 7.14 of the Loan
Agreement. Accordingly, Borrower and Purchaser have

			
		  	requested that Lender consent to the Emergystat Stock Purchase and extend the forbearance period until March 18, 2005.
		
	FIFTH:	  	Lender is willing (i) only upon the terms and conditions set forth in this Agreement, to consent to the Emergystat Stock Purchase, and (ii) only upon the terms and conditions set forth in
that certain letter agreement dated of even date herewith between Borrower and Lender (the “2/1/05 Forbearance Agreement”), to extend the forbearance period.

 ACCORDINGLY, for good and valuable consideration, the parties hereby agree as follows: 

1. Definitions. Unless otherwise defined in this Agreement or in the above Recitals, all capitalized terms used herein shall have the meanings ascribed
to them in the “Forbearance Agreements” as that term is defined in the 2/1/05 Forbearance Agreement. In addition, the following capitalized terms shall have the meanings set forth below: 
 1.1 “Emergystat Closing Date” means the date on which the legal ownership of certain stock of Emergystat, Inc. and of Emergystat
of Sulligent, Inc. is transferred to Southland Health Services pursuant to the Emergystat Purchase Agreement. 
 1.2 “Event of
Default” has the meaning given to it in Section 11 below. 
 1.3 “GE Healthcare”. means GE
Healthcare Financial Services and/or its affiliates, GE Healthcare itself being affiliated with Lender. 
 1.4 “Governmental
Authority” means and includes any federal, state, District of Columbia, county, municipal, or other government and any department, commission, board, bureau, agency or instrumentality thereof, whether domestic or foreign. 
 1.5 “Material Adverse Effect” means any fact, event or circumstance that, alone or when taken with other events or conditions
occurring or existing concurrently with such event or condition (i) has or is reasonably expected to have a material adverse effect on the business, operations, condition (financial or otherwise), assets, liabilities, prospects, or properties of
Purchaser; (ii) has or is reasonably expected to have any material adverse effect on the validity or enforceability of this Agreement; (iii) materially impairs or is reasonably expected to materially impair the ability of Purchaser to perform under
this Agreement; (iv) materially impairs or is reasonably expected to materially impair the ability of Lender to enforce its rights and remedies under this Agreement; or (v) has or is reasonably expected to have any material adverse effect on
Lender’s Collateral. 
 1.6 “paid in full” or “payment in full”, means the
receipt of cash or cash equivalents equal to the full amount of the required payment, including, without limitation, the principal amount, all interest thereon, and all fees and costs actually and reasonably incurred, to the date of such payment;
provided, however, that any such payment in full to Lender shall be indefeasible and any such cash or cash equivalents that Lender may be required to return or disgorge for any reason shall not be deemed to have been paid to
Lender for the purposes of determining whether Lender has been “paid in full”, or received “payment in full”. 
  

 - 2 - 

 1.7 “Person” means an individual, partnership, corporation, trust, joint venture,
joint stock company, limited liability company, association, unincorporated organization, Governmental Authority, or any other entity. 
 1.8
“Southland Closing Date” means the date on which the legal ownership of Southland Health Services is transferred to the Purchaser pursuant to the Southland Purchase Agreement. 
 2. Recitals. By this reference the above Recitals are incorporated into and made a part of the body of this Agreement. 
 3. Payment of Borrower’s Obligations 
 3.1 $500,000 Payment. On the earlier to occur of: (i) the fifteenth day following the Emergystat Closing Date, or (ii) February 15, 2005, Borrower shall pay to Lender, and Purchaser shall cause Borrower to pay to Lender, and
Lender shall have received payment in full, in immediately available funds, of an amount equal to Five Hundred Thousand Dollars ($500,000.00) (the “$500,000 Paydown”). 
 3.2 Payment In Full. On or before March 15, 2005, Borrower shall pay to Lender, and Purchaser shall cause Borrower to pay to Lender, and
Lender shall have received payment in full, in immediately available funds, of the entire amount of the Obligations owing to Lender, as determined by Lender in accordance with the Loan Agreement, the Other Loan Documents, and the Forbearance
Agreements. 
 4. Payment of GE Healthcare Obligations. On or before March 30, 2005, Borrower shall pay to GE Healthcare, and
Purchaser shall cause Borrower to pay to GE Healthcare, and GE Healthcare shall have received payment in full of, in immediately available funds, either: (i) the entire amount of the GE Healthcare Obligations (as that term, not the amount, is
defined in that certain forbearance letter agreement dated January 21, 2005 between Borrower and Lender), or (ii) an amount equal to Two Hundred Fifty Thousand Dollars ($250,000.00). In the event of a payment to GE Healthcare under subdivision (ii)
of this Section 4 and not a payment under subdivision (i) hereof, then on or before April 29, 2005, Borrower shall pay to GE Healthcare, and Purchaser shall cause Borrower to pay to GE Healthcare, and GE Healthcare shall have received payment
in full, in immediately available funds, of the entire amount of the GE Healthcare Obligations. Borrower shall continue to make regularly scheduled payments when due to GE Healthcare with respect to the GE Healthcare Obligations until such time when
GE Healthcare shall have received payment in full of the entire amount of the GE Healthcare Obligations, and nothing contained in this Agreement shall be construed to excuse or extend the time or times when such regularly scheduled payments are
due. 
 5. Obligation Amounts. Each of Borrower and Lender acknowledges and agrees that Schedule “1” attached
hereto (and incorporated herein by this reference) accurately and correctly states the amount of the Obligations due and owing from Borrower to Lender as of February 1, 2005. Each of Borrower and Lender acknowledges and agrees that Schedule
“2” attached hereto (and incorporated herein by this reference) accurately and correctly states the amount of the GE Healthcare Obligations due and owing from Borrower to GE Healthcare as of February 1, 2005. Each of Purchaser and
Borrower understands and acknowledges that: (i) the  

  

 - 3 - 

 
amount of the Obligations may increase between February 1, 2005, and the date of any payment in full of the Obligations, (ii) the amount of the GE Healthcare
Obligations may increase between February 1, 2005, and the date of any payment in full of the GE Healthcare Obligations, and (iii) Borrower, and pursuant to Sections 11.1 through 11.7 of this Agreement, Purchaser, shall be obligated to pay
the entire amount of the Obligations and the GE Healthcare Obligations as of the actual date of any payment in full of the Obligations and the GE Healthcare Obligations. 
 6. Consent. Lender’s consent to the Emergystat Stock Purchase and the Southland Stock Purchase is subject to the full satisfaction of the following conditions: (i) Borrower and Purchaser have
executed and delivered this Agreement to Lender, (ii) Borrower has executed and delivered to Lender the 2/1/05 Forbearance Agreement, (iii) both the Emergystat Closing Date and the Southland Closing Date occur not later than three (3) business days
after the execution and delivery of this Agreement, (iv) prior to the Emergystat Closing Date, there is no modification or amendment to the Purchase Agreement which would change the nature of the purchase from a stock sale to sale of any of
Borrower’s assets constituting Lender’s Collateral, and none of the transactions contemplated by the Emergystat Purchase Agreement or the Southland Purchase Agreement in any way affects the current legal ownership of any of Borrower’s
assets, Lender’s Collateral, or the perfection or priority of Lender’s security interests therein. 
 7. Purchase Agreement;
Stock Purchase. Each of Borrower and Purchaser acknowledges and agrees that Lender has not been privy to or had any involvement with respect to either the Emergystat Purchase Agreement or the Southland Purchase Agreement, the terms thereof,
the initiation thereof, or the negotiations relating thereto. 
 8. GE Healthcare Forbearance Documents. The Emergystat Stock
Purchase constitutes a default under the GE Healthcare Documents. As consideration for the request by Borrower and Purchaser for GE Healthcare’s forbearance from exercising its rights and remedies on account of the Emergystat Stock Purchase,
Borrower shall, and Purchaser shall cause Borrower to, execute and deliver to GE Healthcare each and all of the GE Healthcare Forbearance Documents, all in form, content, and detail acceptable to GE Healthcare in its sole discretion, upon GE
Healthcare’s request, including, but not limited to, documents listed in subsections (i), (ii), and (iii) of Paragraph 4(B) set forth in the Twentieth Forbearance Agreement dated January 21, 2005. By this express reference, the text of such
subsections (i), (ii), and (iii) are incorporated into and made a part of this Section 8 of this Agreement. Each of Borrower and Purchaser understands and acknowledges that notwithstanding any provision set forth in this Agreement, GE
Healthcare does and shall reserve all of its rights and remedies under the GE Healthcare Documents with respect to the Emergystat Stock Purchaser and otherwise. 
 9. Resolution of Enforcement Notice. Purchaser shall cause Borrower to perform fully and timely the requirements set forth in Paragraph C.2 of the 2/1/05 Forbearance Agreement. In addition, in the event
Purchaser has any communications (whether electronic, telephonic, or otherwise) with the IRS with respect to the Enforcement Notice, Purchaser shall immediately notify Lender of such communications and provide to Lender true and complete copies of
all such documented communications, including both communications received by Purchaser and communications transmitted by Purchaser. 
  

 - 4 - 

 10. Representations; Warranties. The representations and warranties made in this Section 10 by
Purchaser are being made to induce Lender to enter into this Agreement and into the 2/1/05 Forbearance Agreement, and Lender has relied, and will continue to rely, upon such representations and warranties from and after the execution and delivery of
this Agreement. Such representations and warranties shall survive until all of the Obligations owed to Lender by Borrower are indefeasibly paid in full. Purchaser represents and warrants to Lender as follows: 
 10.1 Due Diligence. Purchaser is a sophisticated buyer with respect to the Emergystat Stock Purchase, the Emergystat Purchase Agreement,
the Southland Stock Purchase, and the Southland Purchase Agreement and has adequate information concerning the status of the Borrower’s Obligations to Lender and the GE Healthcare Obligations, in order to make an informed decision regarding
Purchaser’s undertaking the obligations set forth in this Agreement. Purchaser has not relied upon statements from Lender or Lender’s counsel (other than any expressly stated in this Agreement) but instead has performed and relied upon
Purchaser’s own independent investigations, inquiries, and evaluations, including, without limitation, meetings with Borrower, all of which were in such depth as Purchaser deemed appropriate under the circumstances. Purchaser has not sought nor
received any information, financial or otherwise, from Lender regarding Borrower. 
 10.2 Capital Stock Sale. The transaction
contemplated by the Emergystat Purchase Agreement is a purchase of no less than ninety percent (90%) of the issued and outstanding capital stock of Emergystat, Inc. and Emergystat of Sulligent, Inc., and the transaction contemplated by the Southland
Purchase Agreement is the purchase of 100% of the issued and outstanding capital stock of Southland Health Services. Neither the Emergystat Purchase Agreement nor the Southland Purchase Agreement provides for the purchase of any assets of Borrower
or any assets constituting Lender’s Collateral securing the Obligations. The Purchase Agreement does not provide for the purchase of any assets of Borrower or any assets constituting Lender’s Collateral securing the Obligations and does
not in any way affect the perfection or priority of Lender’s security interests therein. 
 10.3 Financial Resources.
Purchaser has sufficient assets and financial resources to perform its obligations under this Agreement, including, but not limited to, a Twelve Million Dollar equity line with Cornell Capital Partners, LP (the “Equity
Line”). No event of default under the Equity Line, or event that, with the giving of notice or lapse of time or both, could become an event of default thereunder, has occurred and is continuing. 
 10.4 No Default. Except as disclosed in the Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the
quarterly period ended September 30, 2004 (a true and complete copy of the such disclosures is attached hereto as Schedule 3 and by this reference made a part hereof), Purchaser is not in default under or with respect to any obligation or
agreement in any respect, and no event that, with the giving of notice or lapse of time or both, could become an event of default thereunder, has occurred and is continuing, which would have a Material Adverse Effect. 
 10.5 Organization; Good Standing. Purchaser (i) is a corporation duly organized, validly existing, and in good standing under the laws of
the state of Nevada, (ii) is in good standing as a foreign corporation in each jurisdiction in which the character of the properties owned or leased by it or the nature of its business makes such qualification necessary, (iii) has 

  

 - 5 - 

 
the corporate power and authority to own its assets and transact the business in which it is engaged, and (iv) has obtained all certificates, licenses and
qualifications required under the laws, regulations, ordinances, or orders of public authorities necessary for the ownership and operation of all of its properties and transaction of all of its business, all of which are in the name of Purchaser.
Purchaser’s organizational identification number is 94-3371514. 
 10.6 Authority. Purchaser has full corporate power and
authority to enter into, execute, and deliver this Agreement and to perform its obligations under this Agreement, and to incur and perform the obligations hereunder, all of which have been duly authorized by all necessary corporate action. No
consent or approval of shareholders of Purchaser and no consent, approval, filing or registration with any Governmental Authority is required as a condition to the validity of this Agreement or the performance by Purchaser of its obligations
hereunder. 
 10.7 No Conflicts. Purchaser’s execution and delivery of this Agreement and of the Purchase Agreement do
not, and the performance of its obligations hereunder and thereunder will not, violate, conflict with, or constitute a default under: (i) any provision of Purchaser’s articles of incorporation or bylaws, (ii) any provision of any law, rule, or
regulation applicable to Purchaser, (iii) any indenture or other agreement or instrument to which Purchaser is a party or by which Purchaser or its property is bound, or (iv) any judgment, order or decree of any court, arbitration tribunal, or
Governmental Authority having jurisdiction over Purchaser which is applicable to Purchaser. 
 10.8 Compliance with Laws.
Purchaser has obtained and maintains all governmental consents, franchises, certificates, licenses, authorizations, approvals and permits, the lack of which would have a Material Adverse Effect. Purchaser is in compliance in all material respects
with all applicable federal, state, local and foreign statutes, orders, regulations, rules and ordinances. 
 10.9 Name;
Address. Purchaser’s exact legal name is as set forth in the Preamble to this Agreement. Purchaser has not conducted business under or used any other name other than as set forth in the Preamble to this Agreement. The chief executive
office and principal place of business for Purchaser is located at 2344 Woodridge Avenue, Kingsport, Tennessee 37664. 
 10.10
Litigation. Except as disclosed in the Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2004 (a true and complete copy of the such disclosures is attached
hereto as Schedule 3 and by this reference made a part hereof), there are no actions, suits, proceedings or investigations pending or threatened against Purchaser before any court or arbitrator or before or by any Governmental Authority
which, in any one case or in the aggregate, if determined adversely to the interests of Purchaser, could have a Material Adverse Effect. Purchaser is not in default with respect to any order of any court, arbitrator, or Governmental Authority
applicable to Purchaser or its properties. 
 10.11 Taxes. Purchaser has filed all federal, state and other tax returns which
are required to be filed, and has paid all taxes shown as due on those returns and all assessments, fees and other amounts due as of the date of this Agreement. All tax liabilities of Purchaser are adequately provided for such Purchaser’s
books. No tax liability has been asserted by the 

  

 - 6 - 

 
Internal Revenue Service or other taxing authority against Purchaser for taxes in excess of those already paid. 
 10.12 Benefit to Purchaser. Purchaser acknowledges and agrees that following the Emergystat Closing Date and the Southland Closing Date,
the entities comprising Borrower will be indirect subsidiaries of Purchaser, and Purchaser will own, indirectly, no less than ninety percent (90%) of Emergystat, Inc. and ninety percent (90%) of Emergystat of Sulligent, Inc. Because of the business
relations between Purchaser and Borrower, it will be of direct benefit to Purchaser that it enter into this Agreement and undertake its obligations set forth herein and to assure the payment and performance of Borrower’s obligations under this
Agreement, and such entry into this Agreement will inure to the financial benefit of Purchaser. 
 10.13 2/1/05 Forbearance
Agreement. Purchaser: (i) has received a true and complete copy of the 2/1/05 Forbearance Agreement, (ii) has read the same, and (iii) fully understands the obligations of Borrower thereunder. 
 10.14 Acknowledgement. Purchaser acknowledges and agrees that: (i) all amounts asserted to be due by Lender under the Loan Agreement, the
Other Loan Documents, and the Forbearance Agreements, and all amounts asserted to be due by GE Healthcare under its installment agreements, are justly due and owing to Lender and to GE Healthcare, respectively (including, but not limited to, all
amounts stated in Schedules “1” and “2” attached hereto), without any defense of Borrower or any right of Borrower to set off, recoup, or counterclaim (and, upon acceptance of any advance(s), including, but not limited to,
each Twentieth Overline Funding, (ii) the Loan Agreement, the Other Loan Documents, the Forbearance Agreements, and the GE Healthcare Documents are valid and enforceable against each entity comprising Borrower in accordance with their respective
terms, and are not subject to avoidance under applicable state law or federal law; and (iii) the liens and security interests granted to Lender in the Collateral pursuant to the Loan Agreement and the Other Loan Documents are valid, enforceable, and
properly perfected, and are not subject to avoidance under applicable state law or federal law. 
 11. Purchaser’s Guaranty of Borrower’s
Performance 
 11.1 To induce Lender to consent to the Emergystat Stock Purchase, subject to the terms and conditions of this
Agreement, to enter into the 2/1/05 Forbearance Agreement, and in consideration thereof, Purchaser hereby unconditionally and irrevocably guarantees to Lender, and to its successors, endorsees, transferees, affiliates, and assigns (collectively
encompassed, for purposes of this guaranty by Purchaser set forth in Sections 11.1 through 10.7 hereof, by references to “Lender”), Borrowers’ prompt and complete payment of the amounts set forth in Sections 3.1, 3.2, and 4
above, when due. 
 11.2 The obligations of Purchaser under this Agreement shall be an unconditional obligation to make prompt payment
and performance to Lender regardless of the genuineness, validity, regularity or enforceability of any indebtedness or evidence of indebtedness of Borrower to Lender or of other circumstances that might otherwise under the laws of any jurisdiction
constitute a legal or equitable discharge of a surety or a guarantor or a bar (in the nature of a moratorium or otherwise) to the enforcement of Lender’s rights either (i) against Borrower on all or any part of its Obligations or (ii) under
this Agreement 
  

 - 7 - 

 11.3 Notwithstanding any payment or payments made by Purchaser under this Agreement or any setoff or
application of funds of Purchaser by Lender, Purchaser shall not be entitled to be subrogated to any of the rights of Lender against Borrower or any collateral security or guarantee or right of offset held by Lender for the payment or performance of
the Obligations, nor shall Purchaser seek any reimbursement from Borrower in respect of payments made by Purchaser under this Agreement, until all amounts then owing and any other performance then due to Lender by Borrower for or on account of the
Obligations are paid in full and satisfied in full indefeasibly. 
 11.4 Any indebtedness of Borrower now or hereafter owed to or held by
Purchaser is hereby subordinated to the indebtedness of Borrower to Lender; and such indebtedness of Borrower to Purchaser to Lender so requests shall be collected, enforced and received by Purchaser as trustee for Lender and be paid over to Lender
on account of the indebtedness of Borrower to Lender but without reducing or affecting in any manner the liability of Purchaser under the other provisions of this Agreement. 
 11.5 The undertaking by Purchaser set forth in this Agreement is intended to be and shall be construed as a continuing guarantee and shall remain in full
force and effect and shall be binding in accordance with and to the extent of its terms upon Purchaser and Purchaser’s successors, and shall inure to the benefit of Lender, and its successors, endorsees, transferees, and assigns. 
 11.6 If all or any part of the Obligations of Borrower to Lender are not paid when due as set forth in this Agreement, Purchaser hereby guarantees that
it will pay the same to Lender, upon demand, without set-off or counterclaim and without reduction by reason of any taxes, levies, imposts, charges and withholdings, restrictions or conditions of any nature that are now or may hereafter be imposed,
levied or assessed by any country, political subdivision or taxing authority, all of which will be for the account of and paid by Purchaser, and Lender need not first proceed to preserve, utilize or exhaust any other right or remedy against Borrower
or any other guarantor or any security that Lender may have to obtain payment. The payment shall be made in immediately available funds to Lender’s office at 2 Bethesda Metro Center, Suite 600, Bethesda, Maryland 20814, Attention: Michael
Gardullo, or at such other place as Lender may designate in writing. 
 11.7 In addition, Purchaser hereby covenants that it will not
commence any type of action or proceeding, including, but not limited to, any counterclaim, against either Lender or GE Healthcare with respect to the Obligations, the GE Healthcare Obligations, or the documents evidencing such obligations, or
Sections 11.1 through 11.7 of this Agreement. 
 12. Default and Remedies. (i) Any failure by Purchaser or Borrower, or both, to perform
timely under this Agreement, or (ii) any representation or warranty made by Purchaser in this Agreement, any financial statement, or any statement or representation made in any other certificate, report or opinion delivered to Lender by Purchaser in
connection with this Agreement proves to have been incorrect or misleading in any material respect when made, shall constitute an event of default (“Event of Default”) hereunder. In the event of an Event of Default hereunder,
Lender may exercise any and all remedies available to it under this Agreement, the 2/1/05 Forbearance Agreement, at law, and in equity. 
  

 - 8 - 

 13. Indemnity. Purchaser hereby indemnifies and agrees to defend (with counsel acceptable to Lender) and
hold harmless Lender, its officers, agents and employees (collectively, “Indemnitee”) from and against any liability, loss, cost, expense (including reasonable attorneys’ fees and expenses), claim, damage, suit, action or proceeding
ever suffered or incurred by Lender or in which Lender may ever be or become involved (whether as a party, witness or otherwise) (i) arising from Purchaser’s failure to observe, perform or discharge any of its covenants, obligations, agreements
or duties under this Agreement, (ii) arising from the breach of any of the representations, warranties, or covenants contained in this Agreement, (iii) by reason of this Agreement or the transactions contemplated hereby, or (iv) relating to claims
of any Person with respect to the Emergystat Purchase Agreement, the Emergystat Stock Purchase, the Southland Purchase Agreement, or the Southland Stock Purchase. Notwithstanding any contrary provision in this Agreement, the obligation of Purchaser
under this Section 12 shall survive the payment in full of the Obligations and the termination of this Agreement. 
 14. Miscellaneous.

 14.1 Amendment. This Agreement can be amended or terminated only explicitly in a writing signed by all parties to this
Agreement. 
 14.2 Waiver; Remedies Cumulative. A waiver signed by Lender shall be effective only in the specific instance and
for the specific purpose given. Mere delay or failure to act shall not preclude the exercise or enforcement of any of Lender’s rights or remedies. All rights and remedies of Lender shall be cumulative and may be exercised singularly or
concurrently, at Lender’s option, and the exercise or enforcement of any one such right or remedy shall neither be a condition to nor bar the exercise or enforcement of any other. 
 14.3 Successors and Assigns. This Agreement shall be binding upon Purchaser and Borrower and their respective successors and assigns,
except that neither Purchaser nor Borrower may assign any of their rights or duties under this Agreement without the prior written consent of Lender. This Agreement shall be binding upon and inure to the benefit of Lender and its successors and
assigns. All representations and warranties contained in this Agreement shall survive the execution, delivery and performance of this Agreement and the payment in full of the Obligations. 
 15. Governing Law. This Agreement shall be governed by and construed in accordance with the substantive laws (other than conflict laws) of the State of
Maryland. 
 16. Severability. If any provision or application of this Agreement is held unlawful or unenforceable in any respect, such
illegality or unenforceability shall not affect other provisions or applications which can be given effect and this Agreement shall be construed as if the unlawful or unenforceable provision or application had never been contained in this Agreement
or prescribed by this Agreement. 
 17. Interpretation; Headings. No provision of this Agreement shall be interpreted or construed against any
party because that party or its legal representative drafted that provision. Each of the parties hereto shall be deemed to have drafted this Agreement. The rule of law that provides that ambiguities, inconsistencies and the like shall be construed
against the author of a document or contract shall not apply to this Agreement. The titles of the Sections of this 

  

 - 9 - 

 
Agreement are for convenience of reference only and are not to be considered in construing this Agreement. Any pronoun used in this Agreement shall be deemed
to include singular and plural and masculine, feminine and neuter gender as the case may be. The words “herein,” “hereinabove,” “hereof,” and “hereunder” shall be deemed to refer to this entire Agreement,
except as the context otherwise requires. 
 18. Authorized. This Agreement has been duly and validly authorized by all necessary action on the
part of all parties hereto. 
 19. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall
constitute an original, but which counterparts together shall constitute but one and the same instrument. 
 THE PARTIES HERETO
HEREBY (I) CONSENT TO THE PERSONAL JURISDICTION OF THE STATE AND FEDERAL COURTS LOCATED IN THE STATE OF MARYLAND IN CONNECTION WITH ANY CONTROVERSY RELATED TO THIS AGREEMENT; (II) WAIVE ANY ARGUMENT THAT VENUE IN ANY SUCH FORUM IS NOT CONVENIENT;
AND (III) AGREE THAT A FINAL JUDGMENT IN ANY SUCH SUIT, ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW. 
 EACH PURCHASER AND BORROWER WAIVES ITS RIGHT TO A JURY TRIAL WITH RESPECT TO ANY ACTION OR CLAIM ARISING OUT OF ANY DISPUTE IN CONNECTION WITH THIS
AGREEMENT, ANY RIGHTS, REMEDIES, OBLIGATIONS, OR DUTIES HEREUNDER, OR THE PERFORMANCE OR ENFORCEMENT HEREOF OR THEREOF. Except as prohibited by law, each of Purchaser and Borrower waives any right which it may have to claim or recover in any
litigation referred to in the preceding sentence any special, exemplary, punitive or consequential damages or any damages other than, or in addition to, actual damages. Each Purchaser and Borrower certifies that neither Lender nor any
representative, agent or attorney of Lender has represented, expressly or otherwise, that Lender would not, in event of litigation, seek to enforce the foregoing waivers or other waivers contained in this Agreement. 
 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date and year first above written. 
  

 - 10 - 

									
	“LENDER”	 		 	“BORROWER”
			
	 GENERAL ELECTRIC CAPITAL CORPORATION,
 A DELAWARE CORPORATION
	 		 	EMERGYSTAT, INC, A MISSISSIPPI CORPORATION
					
	 By:
	 	  	 		 	 By:
	 	  
	 Its
	 	  	 		 	 Title
	 	  
			
		 		 	EMERGYSTAT OF SULLIGENT, INC.,
		 		 	AN ALABAMA CORPORATION
					
		 		 		 	 By
	 	  
		 		 		 	 Title
	 	  
			
		 		 	EXTENDED EMERGENCY SERVICES,
		 		 	INC., AN ALABAMA CORPORATION
			
		 		 	MED EXPRESS OF MISSISSIPPI, LLC, A
		 		 	MISSISSIPPI LIMITED LIABILITY
		 		 	COMPANY
					
		 		 		 	 By
	 	  
		 		 		 	 Title
	 	  
			
		 		 	“PURCHASER”
			
		 		 	 BAD TOYS HOLDINGS, INC., A
 NEVADA
CORPORATION

					
		 		 		 	 By
	 	  
		 		 		 	 Title
	 	  

 CONSENT AND AGREEMENT OF GUARANTOR 
 This Consent and Agreement of Guarantor is executed by the undersigned Johnny Glenn Crawford (the “Guarantor”) with respect to the foregoing
Tri-Party Agreement. Guarantor acknowledges receiving and reading the foregoing Tri-Party Agreement. Guarantor hereby consents to the Tri-Party Agreement and to Borrower’s entering into and performing under the foregoing Tri-Party Agreement.
Guarantor further acknowledges and agrees that the Tri-Party Agreement has no affect upon the Guaranty Documents which documents shall continue in full force and effect. 
  

			
	Dated as of the foregoing Tri-Party Agreement.	  	  

  

 - 11 - 

 JOHNNY GLENN CRAWFORD 
 GUARANTOR                         
  

 - 12 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}]]